By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovery, development and commercialization of therapies that degrade disease-causing proteins262.6M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States262.6M100.00%